Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP363812.RA_XHXQ5Iqwy-l28Rz9CM0B-n07BUSLtDb4eaqbEzfrGg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP363812.RA_XHXQ5Iqwy-l28Rz9CM0B-n07BUSLtDb4eaqbEzfrGg130_assertion type Assertion NP363812.RA_XHXQ5Iqwy-l28Rz9CM0B-n07BUSLtDb4eaqbEzfrGg130_head.
- NP363812.RA_XHXQ5Iqwy-l28Rz9CM0B-n07BUSLtDb4eaqbEzfrGg130_assertion wasGeneratedBy ECO_0000203 NP363812.RA_XHXQ5Iqwy-l28Rz9CM0B-n07BUSLtDb4eaqbEzfrGg130_provenance.
- NP363812.RA_XHXQ5Iqwy-l28Rz9CM0B-n07BUSLtDb4eaqbEzfrGg130_assertion wasDerivedFrom befree-20140225 NP363812.RA_XHXQ5Iqwy-l28Rz9CM0B-n07BUSLtDb4eaqbEzfrGg130_provenance.
- NP363812.RA_XHXQ5Iqwy-l28Rz9CM0B-n07BUSLtDb4eaqbEzfrGg130_assertion SIO_000772 11927838 NP363812.RA_XHXQ5Iqwy-l28Rz9CM0B-n07BUSLtDb4eaqbEzfrGg130_provenance.
- NP363812.RA_XHXQ5Iqwy-l28Rz9CM0B-n07BUSLtDb4eaqbEzfrGg130_assertion evidence source_evidence_literature NP363812.RA_XHXQ5Iqwy-l28Rz9CM0B-n07BUSLtDb4eaqbEzfrGg130_provenance.
- NP363812.RA_XHXQ5Iqwy-l28Rz9CM0B-n07BUSLtDb4eaqbEzfrGg130_assertion description "[The NAT2 genotype did not have any significant effect on the risk of developing asthma, but the putative slow acetylator NAT1 genotypes posed a 2.54-fold risk of diisocyanate-induced asthma (95% confidence interval [CI] 1.32 to 4.91).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363812.RA_XHXQ5Iqwy-l28Rz9CM0B-n07BUSLtDb4eaqbEzfrGg130_provenance.